Project organization: University of Delaware

Modernizing clearance and quantification of host-cell proteins in mAb manufacture

Optimizing Next Generation Sequencing for Sensitive Detection of Viral Adventitious Agents in Biologics

An Integrated Platform for Fully Automated, Continuous, & Real-Time Multi-Attributes Monitoring of Upstream Processes for Glycosylated Monoclonal Antibodies Production

Innovative scalable technologies for production of cell therapies

Measuring glycans from biopharmaceuticals using LC-Q/TOF

Cell separation, processing, and expansion for cell therapy applications

Mechanistic Modeling for Enhanced Chromatographic Productivity

Identification, Characterization and Removal of Host-Cell Proteins (HCP) in Chinese Hamster Ovary (CHO) Monoclonal Antibody Biomanufacturing Processes

Adaptive Process Control and Advanced Sensing for Robust mAb Glycan Quality

PI – Sustainability Modeling

Affinity Precipitation Purification of Virus-Like Particles

Establishing Testbeds for Biopharmaceutical Manufacturing Workforce Development in Louisiana, North Carolina, Maryland, Delaware, and Texas